logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
delete
arrow
返回
H

Haoda Fu

Eli Lilly and Company

26H指数
143论文数
3.0K被引数
收录论文 26
发表时间
logo
Dynamic Decision Making With Individualized Variable Selection个性化变量选择的动态决策制定
errJournal of the American Statistical Association
IF3
err2026-08-19
err0
PREAI
errBryan Cai; Ying Cui; Haoda Fu; Donald M. Lloyd-Jones; Lihui Zhao; Tian Lu
err分享
err收藏
Optimal individualized treatment rule for combination treatments under budget constraints
errJOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES B-STATISTICAL METHODOLOGY
IF3.6
err2024-01-10
err0
errOAAI
errXu, Qi; Fu, Haoda; Qu, Annie
err分享
err收藏
Controlling Cumulative Adverse Risk in Learning Optimal Dynamic Treatment Regimens
errJOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION
IF3
err2023-12-11
err0
PREAI
errLiu, Mochuan; Wang, Yuanjia; Fu, Haoda; Zeng, Donglin
err分享
err收藏
Fast Approximation of the Shapley Values Based on Order-of-Addition Experimental Designs
errJOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION
IF3
err2023-10-24
err4
errOAAI
errYang, Liuqing; Zhou, Yongdao; Fu, Haoda; Liu, Min-Qian; Zheng, Wei
err分享
err收藏
Enabling Eating Detection in a Free-living Environment: Integrative Engineering and Machine Learning Study
errJOURNAL OF MEDICAL INTERNET RESEARCH
IF6
err2022-03-01
err0
errOAAI
errZhang, Bo; Deng, Kaiwen; Shen, Jie; Cai, Lingrui; Ratitch, Bohdana; Fu, Haoda; Guan, Yuanfang
err分享
err收藏
Query-Augmented Active Metric Learning
errJOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION
IF3
err2022-01-28
err1
errOAAI
errDeng, Yujia; Yuan, Yubai; Fu, Haoda; Qu, Annie
err分享
err收藏
Model-Assisted Uniformly Honest Inference for Optimal Treatment Regimes in High Dimension模型辅助的一致诚实推理，用于高维的最佳治疗方案
errJOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION
IF3
err2021-07-14
err2
errOAAI
errWu, Yunan; Wang, Lan; Fu, Haoda
err分享
err收藏
Multicategory Angle-Based Learning for Estimating Optimal Dynamic Treatment Regimes With Censored Data
errJOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION
IF3
err2021-02-03
err11
errOAAI
errXue, Fei; Zhang, Yanqing; Zhou, Wenzhuo; Fu, Haoda; Qu, Annie
err分享
err收藏
Multi-Armed Angle-Based Direct Learning for Estimating Optimal Individualized Treatment Rules With Various Outcomes
errJOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION
IF3
err2019-04-11
err45
errOAAI
errQi, Zhengling; Liu, Dacheng; Fu, Haoda; Liu, Yufeng
err分享
err收藏
Robust Alternatives to ANCOVA for Estimating the Treatment Effect via a Randomized Comparative Study
errJOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION
IF3
err2019-03-18
err15
errOAAI
errJiang, Fei; Tian, Lu; Fu, Haoda; Hasegawa, Takahiro; Wei, L. J.
err分享
err收藏
Learning Optimal Personalized Treatment Rules in Consideration of Benefit and Risk: With an Application to Treating Type 2 Diabetes Patients With Insulin Therapies
errJOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION
IF3
err2018-05-16
err57
errOAAI
errWang, Yuanjia; Fu, Haoda; Zeng, Donglin
err分享
err收藏
Adding a new analytical procedure with clinical interpretation in the tool box of survival analysis
errANNALS OF ONCOLOGY
IF65.4
err2018-05-01
err14
errOAAI
errUno, H.; Claggett, B.; Tian, L.; Fu, H.; Huang, B.; Kim, D. H.; Wei, L. J.
err分享
err收藏
Risk Factors for Nocturnal Hypoglycemia in Insulin-treated Patients With Type 2 Diabetes: A Secondary Analysis of Observational Data Derived From an Integrated Clinical Trial Database
errCLINICAL THERAPEUTICS
IF3.6
err2017-09-01
err14
errOAAI
errBae, Jay P.; Duan, Ran; Fu, Haoda; Hoogwerf, Byron J.
err分享
err收藏
Evaluation of Efficacy and Safety of the Glucagon Receptor Antagonist LY2409021 in Patients With Type 2 Diabetes: 12- and 24-Week Phase 2 Studies (vol 39, pg 1241, 2016)
errDIABETES CARE
IF16.6
err2017-04-18
err4
errOAAI
errKazda, Christof M.; Ding, Ying; Kelly, Ronan P.; Garhyan, Parag; Shi, Chunxue; Lim, Chay Ngee; Fu, Haoda; Watson, David E.; Lewin, Andrew J.; Landschulz, William H.; Deeg, Mark A.; Moller, David E.; Hardy, Thomas A.
err分享
err收藏
Evaluation of Efficacy and Safety of the Glucagon Receptor Antagonist LY2409021 in Patients With Type 2 Diabetes: 12-and 24-Week Phase 2 Studies. Diabetes Care 2016;39:1241-1249
errDIABETES CARE
IF16.6
err2016-10-11
err1
errOAAI
errKazda, Christof M.; Ding, Ying; Kelly, Ronan P.; Garhyan, Parag; Shi, Chunxue; Lim, Chay Ngee; Fu, Haoda; Watson, David E.; Lewin, Andrew J.; Landschulz, William H.; Deeg, Mark A.; Moller, David E.; Hardy, Thomas A.
err分享
err收藏
Crossover design and its application in late-phase diabetes studies
errJOURNAL OF DIABETES
IF3.7
err2016-08-18
err9
errOAAI
errWang, Tao; Malone, James; Fu, Haoda; Heilmann, Cory; Qu, Yongming; Huster, William J.
err分享
err收藏
Perspectives on Some Controversies in Cardiovascular Disease Risk Assessment in the Pharmaceutical Development of Glucose-Lowering Medications
errDIABETES CARE
IF16.6
err2016-07-16
err9
errOAAI
errHoogwerf, Byron J.; Manner, David H.; Fu, Haoda; Moscarelli, Elena; Gaydos, Brenda L.; Heine, Robert J.
err分享
err收藏
Jointly Modeling Label and Feature Heterogeneity in Medical Informatics
errACM TRANSACTIONS ON KNOWLEDGE DISCOVERY FROM DATA
IF4.8
err2016-05-11
err7
errOAAI
errYang, Pei; Yang, Hongxia; Fu, Haoda; Zhou, Dawei; Ye, Jieping; Lappas, Theodoros; He, Jingrui
err分享
err收藏
Evaluation of Efficacy and Safety of the Glucagon Receptor Antagonist LY2409021 in Patients With Type 2 Diabetes: 12-and 24-Week Phase 2 Studies
errDIABETES CARE
IF16.6
err2015-12-17
err158
errOAAI
errKazda, Christof M.; Ding, Ying; Kelly, Ronan P.; Garhyan, Parag; Shi, Chunxue; Lim, Chay Ngee; Fu, Haoda; Watson, David E.; Lewin, Andrew J.; Landschulz, William H.; Deeg, Mark A.; Moller, David E.; Hardy, Thomas A.
err分享
err收藏
Alternatives to Hazard Ratios for Comparing the Efficacy or Safety of Therapies in Noninferiority Studies
errANNALS OF INTERNAL MEDICINE
IF15.2
err2015-07-21
err190
errOAAI
errUno, Hajime; Wittes, Janet; Fu, Haoda; Solomon, Scott D.; Claggett, Brian; Tian, Lu; Cai, Tianxi; Pfeffer, Marc A.; Evans, Scott R.; Wei, Lee-Jen
err分享
err收藏

研究方向

暂无研究方向
合作学者
合作期刊
S
Scott D. Solomon
H 指数: 188 · 论文数: 2.0K
M
Marc A. Pfeffer
H 指数: 167 · 论文数: 876
D
Donald M. Lloyd‐Jones
H 指数: 144 · 论文数: 1.5K
R
Robert J. Heine
H 指数: 103 · 论文数: 664
J
Jieping Ye
H 指数: 103 · 论文数: 693
查看更多